Merck BRAVECTO QUANTUM Approved for Year-Long Tick Protection
RAHWAY, N.J., March 2026 Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved BRAVECTO®...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
RAHWAY, N.J., March 2026 Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved BRAVECTO®...
RAHWAY, N.J. | October 23, 2025 — Merck Animal Health (MSD Animal Health outside the U.S. and Canada), a...
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
